This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in subjects with solid tumor or lymphoma.

The aim of this study was to explore the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in patients with solid tumors or lymphoma.

Inclusion Criteria:

1. Participants who were diagnosed with malignant tumors;
2. Patients are between 18 and 80 years of age are between 18 and 80 years of age.

Exclusion Criteria:

1. Participants who were unable or unwilling to provide written informed consent.
2. Participants who were unable to successfully complete the examination and are forced to abort the test in the middle of the test